Growth Metrics

AC Immune (ACIU) Amortization (2016 - 2019)

AC Immune has reported Amortization over the past 4 years, most recently at $109614.7 for Q3 2019.

  • Quarterly Amortization changed N/A to $109614.7 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $5.9 billion through Sep 2019, changed N/A year-over-year, with the annual reading at $5.6 million for FY2021, 18.9% up from the prior year.
  • Amortization was $109614.7 for Q3 2019 at AC Immune, down from $3.3 million in the prior quarter.
  • Over five years, Amortization peaked at $3.5 billion in Q2 2018 and troughed at $109614.7 in Q3 2019.
  • The 4-year median for Amortization is $3.3 million (2018), against an average of $1.2 billion.
  • Year-over-year, Amortization surged 72743.42% in 2017 and then tumbled 99.86% in 2018.
  • A 4-year view of Amortization shows it stood at $3.3 million in 2016, then surged by 72743.42% to $2.4 billion in 2017, then tumbled by 99.86% to $3.3 million in 2018, then tumbled by 96.72% to $109614.7 in 2019.
  • Per Business Quant, the three most recent readings for ACIU's Amortization are $109614.7 (Q3 2019), $3.3 million (Q4 2018), and $3.5 billion (Q2 2018).